Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novavax Inc. sell geldnutzer

Start price
€117.42
20.10.21 / 60%
Target price
€105.00
20.10.22
Performance (%)
24.32%
End price
€145.98
11.11.21
Summary
This prediction ended on 11.11.21 with a price of €145.98. The prediction closed with a disappointing performance of 24.32%. geldnutzer has 60% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Novavax Inc. -9.013% -9.013% -56.805%
iShares Core DAX® -1.670% -1.001% 10.864%
iShares Nasdaq 100 -4.184% -1.145% 37.458%
iShares Nikkei 225® -4.967% -5.783% 18.828%
iShares S&P 500 -2.834% -0.572% 25.875%

According to geldnutzer what are the pros and cons of Novavax Inc. for the foreseeable future?

Pros
Normal challenges to pay loans and raise capital
Cons
Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Dependend from some customers or products
Higher risks for its business
Sustainability is little important
Significant cyclical dependencies
Lower EBIT Margin than peer group
Bad rating
EBIT decline > 20% expected
Growths slower than the competition
Risky balance sheet
High valuation
Probably not worthwhile Investment
Bad culture
Little innovation
Few uniques
Below average Marketposition
Little known brand
Below average Management
Revenue decline > 20% expected
Little Investments for future growth
Business model of the past or high risk

Comments by geldnutzer for this prediction

In the thread Novavax Inc. diskutieren
Prediction Sell
Perf. (%) 24.32%
Target price 55.000
Change
Ends at 20.10.22

Sell mit Kursziel 55,0

Prediction Sell
Perf. (%) 24.32%
Target price 105.000
Change
Ends at 20.10.22

Kursziel geändert auf 105,0

In the thread Trading Novavax Inc.
Prediction Sell
Perf. (%) 24.32%
Target price 105.000
Change
Ends at 20.10.22

Sell beendet

Stopped prediction by geldnutzer for Novavax Inc.

Novavax Inc.

Start price
Target price
Perf. (%)
€11.01
11.01.23
€6.00
11.01.24
-61.64%
12.01.24

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€21.36
13.10.22
€20.00
13.10.23
-48.44%
11.01.23

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Novavax Inc.

Start price
Target price
Perf. (%)
€34.98
27.08.22
€16.00
27.08.23
-38.94%
13.10.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€51.80
27.05.22
€68.00
27.05.23
-32.47%
27.08.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Novavax Inc.

Start price
Target price
Perf. (%)
€42.61
25.05.22
€40.00
25.05.23
21.57%
27.05.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€55.10
03.05.22
€60.00
03.05.23
-22.67%
25.05.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
Novavax Inc.

Start price
Target price
Perf. (%)
€52.93
11.04.22
€40.00
11.04.23
4.10%
03.05.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€145.98
11.11.21
€75.00
11.11.22
-63.74%
11.04.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float